- Home
- Knowledge library
- Use of vaccines in sheep
Use of vaccines in sheep
Latest figures on the uptake of sheep vaccinations across the UK between 2012 and 2023.
Summary points for sheep vaccines
Vaccine sales
Many factors contribute to fluctuations in vaccine sales, including changes in the dose regimes along with manufacturing and supply issues. Sales from wholesalers do not necessarily equate to use in that year. However, it is still useful in estimating the likely level of protection in the target group.
The total number of sheep vaccine doses sold, increased by 13.9% between 2012 and 2022. This dropped in 2023, with a 3.4% increase compared to 2012. In 2023, 37.1 million sheep vaccine doses were sold in 2023.
The number of doses of footrot vaccines sold annually rose by 64.9% between 2012 and 2023. The uptake for Toxoplasma rose by 11.7% and for EAE rose by 6.6% between 2012 and 2023.
Table 1. Uptake of vaccination (%) for sheep in the UK between 2012–2023
| 2012 | 2013 | 2014 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|
Total sheep and lambs | 32,214,916 | 32,856,476 | 33,743,346 | 32,697,441 | 32,957,022 | 33,066,478 | 31,802,536 | |
Clostridial vaccine | 60% | 50% | 51% | 57% | 63% | 65% | 60% | |
Pasteurellosis vaccine | 46% | 39% | 39% | 46% | 51% | 52% | 48% | |
Total breeding flock 1 year and over | 15,229,456 | 15,561,296 | 16,026,113 | 15,369,528 | 15,624,233 | 15,779,210 | 15,437,826 | |
Ewes intended for further breeding and for slaughter | 12,798,594 | 12,997,571 | 13,514,783 | 12,817,226 | 13,018,696 | 13,037,829 | 12,859,785 | |
Toxoplasma vaccine |
26% | 22% | 23% | 31% | 31% | 20% | 29% | |
EAE vaccines | 44% | 33% | 38% | 50% | 50% | 44% | 46% | |
Total breeding flock 1 year and over | 15,229,456 | 15,561,296 | 16,026,113 | 15,369,528 | 15,624,233 | 15,779,210 | 15,437,826 | |
Rams | 391,907 | 432,222 | 417,435 | 392,741 | 402,288 | 389,503 | 387,438 | |
% sheep vaccinated for Footrot | 11% | 10% | 11% | 16% | 19% | 16% | 18% | |
Total doses of vaccine sold | 32,582,366 | 27,627,327 | 29,473,631 | 32,989,535 | 36,681,012 | 37,105,234 | 33,681,225 |
Vaccine use analysis
The analysis includes no estimates about how effectively these vaccines are administered in sheep.
Alongside other management interventions, the use of vaccinations is an important measure to maintain a healthy national flock, prevent disease and use antibiotics responsibly.
With this in mind, it is reassuring that enzootic abortion vaccinations uptake have increased since 2022. Following a supply chain issue in 2022, uptake of toxoplasmosis vaccines appear to have recovered. In addition to a small increase of 2% in footrot vaccinations compared to the previous year.
Uptake has decreased for clostridial (-5%) and pasteurella vaccinations (-4%), which can be attributed to supply chain issues.
Clostridial vaccines in sheep
Clostridial disease is the most common cause of sudden death of all ages of sheep in the UK. Cheap and highly effective multivalent vaccines are available.
Find out about clostridial vaccines
Pasteurellosis vaccines in sheep
Pasteurellosis is one of the most common causes of death in growing lambs in Great Britain, despite there being effective vaccines that offer protection against disease.
Read more about pasteurellosis vaccines
Abortion vaccines in sheep
The control of enzootic abortion was identified as one of three hotspot areas for the reduction of antibiotics in the sheep industry. There are effective abortion vaccines for the three main infectious causes of abortion; the use of these should be discussed with your vet.
More information on abortion vaccines
Lameness vaccines in sheep
Lameness in sheep flocks is one of the most common and persistent disease problems, with scald, footrot (caused by Dichelobacter nodosus) and contagious ovine digital dermatitis (caused by treponemes) being common infectious causes.
Find out more about lameness vaccines
Useful links
Identify, treat and prevent lameness in your flock